PLX3397 demonstrates prolonged tumour regression in TGCT
30 July 2015 | By Victoria White
Clinical trial results demonstrate that PLX3397 induced prolonged tumour regressions in most patients with tenosynovial giant cell tumour (TGCT)...
List view / Grid view
News
Eisai’s Lenvima receives Breakthrough Therapy designation for renal cell carcinoma
29 July 2015 | By Victoria White
Eisai has received a Breakthrough Therapy designation for Lenvima for the potential indication of advanced and/or metastatic renal cell carcinoma...
Study finds pharma firms “underinvest” in long-term cancer research
29 July 2015 | By Victoria White
A study has found firms "underinvest" in long-term research to develop new cancer drugs due to the greater time and cost required to conduct such research...
Mereo BioPharma raises $119m and acquires a clinical product portfolio from Novartis
29 July 2015 | By Victoria White
Mereo BioPharmahas successfully raised $119m and simultaneously acquired a portfolio of three innovative clinical-stage development programmes from Novartis...
NICE recommends three new treatments for hepatitis C in draft guidance
29 July 2015 | By Victoria White
The UK National Institute for Health and Care Excellence has published draft guidance recommending three different treatment options for hepatitis C...
MaSTherCell to manufacture TxCell’s lead product Ovasave
29 July 2015 | By Victoria White
TxCell and MaSTherCell have signed a Memorandum of Understanding for the manufacturing by MaSTherCell of clinical batches of TxCell’s Ovasave...
Sanofi’s first LixiLan Phase III study meets primary endpoint
29 July 2015 | By Victoria White
Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin...
Teva files MAA for asthma treatment reslizumab
28 July 2015 | By Victoria White
Teva has successfully filed a MAA with the EMA for reslizumab -a humanised anti-IL-5 monoclonal antibody for the treatment of inadequately controlled asthma...
Atezolizumab could spur bladder cancer treatment innovation
28 July 2015 | By Victoria White
Atezolizumab is poised to become a major bladder cancer therapy in the race for FDA approval, following its promising performance in recent Phase II trials...
Africa risks large meningitis C outbreak
28 July 2015 | By Victoria White
Four public health organisations have warned of acute shortages of meningitis C-containing vaccine as the risk of a meningitis C outbreak in Africa grows...
PHE publishes annual report on hepatitis C
28 July 2015 | By Victoria White
The latest figures from Public Health England show hospital admissions from hepatitis C-related end-stage liver disease and liver cancer continue to rise...
Sanofi Pasteur’s dengue vaccine candidate safely protects pre-adolescents
28 July 2015 | By Victoria White
New data analyses provide a comprehensive picture of the potential public health impact of vaccinating pre-adolescents and adults against dengue...
Boehringer Ingelheim obtains exclusive rights to HM61713
28 July 2015 | By Victoria White
Boehringer Ingelheim has entered an exclusive and collaboration agreement for the development and global commercialisation rights of HM61713...
Teva withdraws proposal to acquire Mylan
28 July 2015 | By Victoria White
Following yesterday’s news that Teva is to acquire Allergan’s global generics business, Teva has withdrawn its cash and stock proposal to acquire Mylan...
Fungal resistance represents a huge healthcare threat, warns ESCMID
28 July 2015 | By Victoria White
ESCMID is imploring global healthcare professionals and bodies to take a more active role in the growing problem of fungal resistance...
